2-[3-[3-deuterio-5-(2,6-diphenyl-4-pyridinyl)phenyl]phenyl]-3-phenylimidazo[1,2-a]pyridine;2-[3-[3-(2,6-diphenyl-4-pyridinyl)phenyl]phenyl]-3-phenylimidazo[1,2-a]pyridine;2-phenyl-3-[3-[3-phenyl-5-[3-(3-phenylimidazo[1,2-a]pyridin-2-yl)phenyl]phenyl]phenyl]quinoxaline

C135H92N10 — CID 165059818

IUPAC2-[3-[3-deuterio-5-(2,6-diphenyl-4-pyridinyl)phenyl]phenyl]-3-phenylimidazo[1,2-a]pyridine;2-[3-[3-(2,6-diphenyl-4-pyridinyl)phenyl]phenyl]-3-phenylimidazo[1,2-a]pyridine;2-phenyl-3-[3-[3-phenyl-5-[3-(3-phenylimidazo[1,2-a]pyridin-2-yl)phenyl]phenyl]phenyl]quinoxaline
SMILES[2H]c1cc(-c2cccc(-c3nc4ccccn4c3-c3ccccc3)c2)cc(-c2cc(-c3ccccc3)nc(-c3ccccc3)c2)c1.c1ccc(-c2cc(-c3cccc(-c4cccc(-c5nc6ccccn6c5-c5ccccc5)c4)c3)cc(-c3ccccc3)n2)cc1.c1ccc(-c2cc(-c3cccc(-c4nc5ccccc5nc4-c4ccccc4)c3)cc(-c3cccc(-c4nc5ccccn5c4-c4ccccc4)c3)c2)cc1
InChIInChI=1S/C51H34N4.2C42H29N3/c1-4-16-35(17-5-1)42-32-43(38-22-14-24-40(30-38)49-48(36-18-6-2-7-19-36)52-45-26-10-11-27-46(45)53-49)34-44(33-42)39-23-15-25-41(31-39)50-51(37-20-8-3-9-21-37)55-29-13-12-28-47(55)54-50;2*1-4-14-30(15-5-1)38-28-37(29-39(43-38)31-16-6-2-7-17-31)35-22-12-20-33(26-35)34-21-13-23-36(27-34)41-42(32-18-8-3-9-19-32)45-25-11-10-24-40(45)44-41/h1-34H;2*1-29H/i;12D;
InChIKeyRACLFWBQAJXZBC-KQKVFAITSA-N
MW1855.30 g/mol
LogP34.41
Rot. Bonds19

About 2-[3-[3-deuterio-5-(2,6-diphenyl-4-pyridinyl)phenyl]phenyl]-3-phenylimidazo[1,2-a]pyridine;2-[3-[3-(2,6-diphenyl-4-pyridinyl)phenyl]phenyl]-3-phenylimidazo[1,2-a]pyridine;2-phenyl-3-[3-[3-phenyl-5-[3-(3-phenylimidazo[1,2-a]pyridin-2-yl)phenyl]phenyl]phenyl]quinoxaline

2-[3-[3-deuterio-5-(2,6-diphenyl-4-pyridinyl)phenyl]phenyl]-3-phenylimidazo[1,2-a]pyridine;2-[3-[3-(2,6-diphenyl-4-pyridinyl)phenyl]phenyl]-3-phenylimidazo[1,2-a]pyridine;2-phenyl-3-[3-[3-phenyl-5-[3-(3-phenylimidazo[1,2-a]pyridin-2-yl)phenyl]phenyl]phenyl]quinoxaline (PubChem CID 165059818) has the molecular formula C135H92N10 and a molecular weight of 1855.30 g/mol. Its IUPAC name is 2-[3-[3-deuterio-5-(2,6-diphenyl-4-pyridinyl)phenyl]phenyl]-3-phenylimidazo[1,2-a]pyridine;2-[3-[3-(2,6-diphenyl-4-pyridinyl)phenyl]phenyl]-3-phenylimidazo[1,2-a]pyridine;2-phenyl-3-[3-[3-phenyl-5-[3-(3-phenylimidazo[1,2-a]pyridin-2-yl)phenyl]phenyl]phenyl]quinoxaline.

Molecular Properties

Compound Name2-[3-[3-deuterio-5-(2,6-diphenyl-4-pyridinyl)phenyl]phenyl]-3-phenylimidazo[1,2-a]pyridine;2-[3-[3-(2,6-diphenyl-4-pyridinyl)phenyl]phenyl]-3-phenylimidazo[1,2-a]pyridine;2-phenyl-3-[3-[3-phenyl-5-[3-(3-phenylimidazo[1,2-a]pyridin-2-yl)phenyl]phenyl]phenyl]quinoxaline
PubChem CID165059818
Molecular FormulaC135H92N10
Molecular Weight1855.30 g/mol
Exact Mass1853.76
IUPAC Name2-[3-[3-deuterio-5-(2,6-diphenyl-4-pyridinyl)phenyl]phenyl]-3-phenylimidazo[1,2-a]pyridine;2-[3-[3-(2,6-diphenyl-4-pyridinyl)phenyl]phenyl]-3-phenylimidazo[1,2-a]pyridine;2-phenyl-3-[3-[3-phenyl-5-[3-(3-phenylimidazo[1,2-a]pyridin-2-yl)phenyl]phenyl]phenyl]quinoxaline
SMILES[2H]c1cc(-c2cccc(-c3nc4ccccn4c3-c3ccccc3)c2)cc(-c2cc(-c3ccccc3)nc(-c3ccccc3)c2)c1.c1ccc(-c2cc(-c3cccc(-c4cccc(-c5nc6ccccn6c5-c5ccccc5)c4)c3)cc(-c3ccccc3)n2)cc1.c1ccc(-c2cc(-c3cccc(-c4nc5ccccc5nc4-c4ccccc4)c3)cc(-c3cccc(-c4nc5ccccn5c4-c4ccccc4)c3)c2)cc1
InChIInChI=1S/C51H34N4.2C42H29N3/c1-4-16-35(17-5-1)42-32-43(38-22-14-24-40(30-38)49-48(36-18-6-2-7-19-36)52-45-26-10-11-27-46(45)53-49)34-44(33-42)39-23-15-25-41(31-39)50-51(37-20-8-3-9-21-37)55-29-13-12-28-47(55)54-50;2*1-4-14-30(15-5-1)38-28-37(29-39(43-38)31-16-6-2-7-17-31)35-22-12-20-33(26-35)34-21-13-23-36(27-34)41-42(32-18-8-3-9-19-32)45-25-11-10-24-40(45)44-41/h1-34H;2*1-29H/i;12D;
InChIKeyRACLFWBQAJXZBC-KQKVFAITSA-N
XLogP34.41
TPSA103.46 Ų
H-Bond Donors
H-Bond Acceptors10
Rotatable Bonds19
Heavy Atoms145
Complexity—

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 5001855.30
LogP ≤ 534.41
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1010

Analyze 2-[3-[3-deuterio-5-(2,6-diphenyl-4-pyridinyl)phenyl]phenyl]-3-phenylimidazo[1,2-a]pyridine;2-[3-[3-(2,6-diphenyl-4-pyridinyl)phenyl]phenyl]-3-phenylimidazo[1,2-a]pyridine;2-phenyl-3-[3-[3-phenyl-5-[3-(3-phenylimidazo[1,2-a]pyridin-2-yl)phenyl]phenyl]phenyl]quinoxaline with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

2-phenyl-3-[3-[3-phenyl-5-[4-(3-phenylimidazo[1,2-a]pyridin-2-yl)phenyl]phenyl]phenyl]quinoxaline
CID 164781299
2-phenyl-3-[3-[3-phenyl-5-[4-(3-phenylimidazo[1,2-a]pyridin-2-yl)phenyl]phenyl]phenyl]quinoxaline;2-phenyl-3-[4-[3-phenyl-5-[4-(3-phenylimidazo[1,2-a]pyridin-2-yl)phenyl]phenyl]phenyl]quinoxaline;2-phenyl-3-[3-phenyl-5-[4-(3-phenylimidazo[1,2-a]pyridin-2-yl)phenyl]phenyl]quinoxaline
CID 164994147
2-(4-phenylphenyl)-3-[3-[4-phenyl-6-[3-[2-(4-phenylphenyl)imidazo[1,2-a]pyridin-3-yl]phenyl]-2-pyridinyl]phenyl]imidazo[1,2-a]pyridine
CID 164781069
5-phenyl-2-[4-phenyl-6-[3-(3-phenylimidazo[1,2-a]pyridin-2-yl)phenyl]-2-pyridinyl]phenol
CID 169318160
3-phenyl-2-[3-[3-phenyl-5-[4-phenyl-6-(4-phenylphenyl)-1,3,5-triazin-2-yl]phenyl]phenyl]imidazo[1,2-a]pyridine
CID 164781284
3-phenyl-2-[4-phenyl-6-[4-phenyl-6-[4-phenyl-6-(3-phenylimidazo[1,2-a]pyridin-2-yl)-2-pyridinyl]-2-pyridinyl]-2-pyridinyl]imidazo[1,2-a]pyridine
CID 155307009
2-phenyl-3-[3-[2-phenyl-6-[3-(2-phenylimidazo[1,2-a]pyridin-3-yl)phenyl]pyrimidin-4-yl]phenyl]imidazo[1,2-a]pyridine
CID 155306963
bis(3-[4-[4,6-bis(4-phenylphenyl)pyrimidin-2-yl]phenyl]-2-naphthalen-2-ylimidazo[1,2-a]pyridine);3-[4-[4,6-bis(4-phenylphenyl)pyrimidin-2-yl]phenyl]-2-phenylimidazo[1,2-a]pyridine
CID 159888199
3-[3-[3-(2,6-diphenyl-3-pyridinyl)-5-phenanthren-9-ylphenyl]phenyl]-2-phenylimidazo[1,2-a]pyridine;3-[3-[3-(2,6-diphenyl-4-pyridinyl)-5-phenanthren-9-ylphenyl]phenyl]-2-phenylimidazo[1,2-a]pyridine;3-[3-[3-(4,6-diphenyl-2-pyridinyl)-5-phenanthren-9-ylphenyl]phenyl]-2-phenylimidazo[1,2-a]pyridine
CID 164984290
3-phenyl-2-[4-phenyl-6-[2-phenyl-6-[4-phenyl-6-(3-phenylimidazo[1,2-a]pyridin-2-yl)-2-pyridinyl]pyrimidin-4-yl]-2-pyridinyl]imidazo[1,2-a]pyridine
CID 164780995
3-phenyl-2-[3-[4-[4-phenyl-6-(2-phenylphenyl)-1,3,5-triazin-2-yl]phenyl]phenyl]imidazo[1,2-a]pyridine
CID 168835790
2-[4-(2,6-dimethylphenyl)-6-[3-(3-phenylimidazo[1,2-a]pyridin-2-yl)phenyl]-2-pyridinyl]-5-phenylphenol
CID 169318249

Frequently Asked Questions

What is the IUPAC name of 2-[3-[3-deuterio-5-(2,6-diphenyl-4-pyridinyl)phenyl]phenyl]-3-phenylimidazo[1,2-a]pyridine;2-[3-[3-(2,6-diphenyl-4-pyridinyl)phenyl]phenyl]-3-phenylimidazo[1,2-a]pyridine;2-phenyl-3-[3-[3-phenyl-5-[3-(3-phenylimidazo[1,2-a]pyridin-2-yl)phenyl]phenyl]phenyl]quinoxaline?
The IUPAC name of 2-[3-[3-deuterio-5-(2,6-diphenyl-4-pyridinyl)phenyl]phenyl]-3-phenylimidazo[1,2-a]pyridine;2-[3-[3-(2,6-diphenyl-4-pyridinyl)phenyl]phenyl]-3-phenylimidazo[1,2-a]pyridine;2-phenyl-3-[3-[3-phenyl-5-[3-(3-phenylimidazo[1,2-a]pyridin-2-yl)phenyl]phenyl]phenyl]quinoxaline (CID 165059818) is 2-[3-[3-deuterio-5-(2,6-diphenyl-4-pyridinyl)phenyl]phenyl]-3-phenylimidazo[1,2-a]pyridine;2-[3-[3-(2,6-diphenyl-4-pyridinyl)phenyl]phenyl]-3-phenylimidazo[1,2-a]pyridine;2-phenyl-3-[3-[3-phenyl-5-[3-(3-phenylimidazo[1,2-a]pyridin-2-yl)phenyl]phenyl]phenyl]quinoxaline.
What is the SMILES notation for 2-[3-[3-deuterio-5-(2,6-diphenyl-4-pyridinyl)phenyl]phenyl]-3-phenylimidazo[1,2-a]pyridine;2-[3-[3-(2,6-diphenyl-4-pyridinyl)phenyl]phenyl]-3-phenylimidazo[1,2-a]pyridine;2-phenyl-3-[3-[3-phenyl-5-[3-(3-phenylimidazo[1,2-a]pyridin-2-yl)phenyl]phenyl]phenyl]quinoxaline?
The canonical SMILES for 2-[3-[3-deuterio-5-(2,6-diphenyl-4-pyridinyl)phenyl]phenyl]-3-phenylimidazo[1,2-a]pyridine;2-[3-[3-(2,6-diphenyl-4-pyridinyl)phenyl]phenyl]-3-phenylimidazo[1,2-a]pyridine;2-phenyl-3-[3-[3-phenyl-5-[3-(3-phenylimidazo[1,2-a]pyridin-2-yl)phenyl]phenyl]phenyl]quinoxaline is [2H]c1cc(-c2cccc(-c3nc4ccccn4c3-c3ccccc3)c2)cc(-c2cc(-c3ccccc3)nc(-c3ccccc3)c2)c1.c1ccc(-c2cc(-c3cccc(-c4cccc(-c5nc6ccccn6c5-c5ccccc5)c4)c3)cc(-c3ccccc3)n2)cc1.c1ccc(-c2cc(-c3cccc(-c4nc5ccccc5nc4-c4ccccc4)c3)cc(-c3cccc(-c4nc5ccccn5c4-c4ccccc4)c3)c2)cc1.
What is the InChIKey of 2-[3-[3-deuterio-5-(2,6-diphenyl-4-pyridinyl)phenyl]phenyl]-3-phenylimidazo[1,2-a]pyridine;2-[3-[3-(2,6-diphenyl-4-pyridinyl)phenyl]phenyl]-3-phenylimidazo[1,2-a]pyridine;2-phenyl-3-[3-[3-phenyl-5-[3-(3-phenylimidazo[1,2-a]pyridin-2-yl)phenyl]phenyl]phenyl]quinoxaline?
The InChIKey is RACLFWBQAJXZBC-KQKVFAITSA-N. The full InChI is InChI=1S/C51H34N4.2C42H29N3/c1-4-16-35(17-5-1)42-32-43(38-22-14-24-40(30-38)49-48(36-18-6-2-7-19-36)52-45-26-10-11-27-46(45)53-49)34-44(33-42)39-23-15-25-41(31-39)50-51(37-20-8-3-9-21-37)55-29-13-12-28-47(55)54-50;2*1-4-14-30(15-5-1)38-28-37(29-39(43-38)31-16-6-2-7-17-31)35-22-12-20-33(26-35)34-21-13-23-36(27-34)41-42(32-18-8-3-9-19-32)45-25-11-10-24-40(45)44-41/h1-34H;2*1-29H/i;12D;.
What are the key properties of 2-[3-[3-deuterio-5-(2,6-diphenyl-4-pyridinyl)phenyl]phenyl]-3-phenylimidazo[1,2-a]pyridine;2-[3-[3-(2,6-diphenyl-4-pyridinyl)phenyl]phenyl]-3-phenylimidazo[1,2-a]pyridine;2-phenyl-3-[3-[3-phenyl-5-[3-(3-phenylimidazo[1,2-a]pyridin-2-yl)phenyl]phenyl]phenyl]quinoxaline?
2-[3-[3-deuterio-5-(2,6-diphenyl-4-pyridinyl)phenyl]phenyl]-3-phenylimidazo[1,2-a]pyridine;2-[3-[3-(2,6-diphenyl-4-pyridinyl)phenyl]phenyl]-3-phenylimidazo[1,2-a]pyridine;2-phenyl-3-[3-[3-phenyl-5-[3-(3-phenylimidazo[1,2-a]pyridin-2-yl)phenyl]phenyl]phenyl]quinoxaline has a molecular weight of 1855.30 g/mol, XLogP of 34.41, 19 rotatable bonds, 0 hydrogen bond donors, and 10 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[3-[3-deuterio-5-(2,6-diphenyl-4-pyridinyl)phenyl]phenyl]-3-phenylimidazo[1,2-a]pyridine;2-[3-[3-(2,6-diphenyl-4-pyridinyl)phenyl]phenyl]-3-phenylimidazo[1,2-a]pyridine;2-phenyl-3-[3-[3-phenyl-5-[3-(3-phenylimidazo[1,2-a]pyridin-2-yl)phenyl]phenyl]phenyl]quinoxaline is sourced from PubChem (CID 165059818), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).